Estimation of lipoperoxidative damage and antioxidant status in diabetic children:: Relationship with individual antioxidants

被引:46
作者
Martín-Gallán, P
Carrascosa, A
Gussinye, M
Domínguez, C
机构
[1] Univ Barcelona, Biochem & Mol Biol Ctr, Hosp Gen Valle Hebron, Barcelona, Spain
[2] Univ Barcelona, Paediat Endocrinol Unit, Hosp Gen Valle Hebron, Barcelona, Spain
关键词
diabetic children; antioxidants; malondialdehyde; plasma oxidizability; lipidperoxidation;
D O I
10.1080/10715760500156751
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Increased oxidative stress has emerged as a potential mechanism implicated in the pathogenesis, progression and cell dysfunction associated with many diseases including diabetes. In routine clinical practice, the estimation of the degree of oxidative damage and antioxidant status, even in paediatric patients, by appropriate techniques appears to be of interest. The aim of this study was to reliably identify patients with increased oxidant stress and/or reduced antioxidant defence mechanisms with a small blood sample and verify the applicability to the study of diabetic children (DC) at clinical onset of the disease. In 1-ml blood samples from 30 DC and 34 controls, techniques for accurately measuring malondialdehyde (MDA) concentrations in plasma and erythrocytes (using HPLC analysis with fluorometric detection), total radical antioxidant potential (TRAP) and blood plasma oxidizability were adapted and validated. Plasma alpha-tocopherol (HPLC), uric acid and sulfhydryl (SH) groups were also determined. At clinical onset of diabetes a significant reduction in plasma TRAP values (P < 0.01) was observed in DC compared with controls. Similarly, a significant fall in individual antioxidant levels (alpha-tocopherol/total lipids, uric acid and protein SH) was noted in plasma of DC. Highly significant increases were found in both plasma and erythrocyte MDA levels in DC (p-MDA: 1.7 +/- 0.2 mu M; er-MDA: 7.2 +/- 0.7 nmol/g Hb) compared with controls (p-MDA:0.86 +/- 0.09 mu M; P < 0.0003; er-MDA:3.8 +/- 0.2 nmol/g Hb, P < 0.0001). Plasma MDA and triglyceride levels correlated directly only in DC (P < 0.001). Whole plasma oxidizability was significantly higher in DC than in controls (P < 0.0001) and this parameter correlated significantly with plasma cholesterol and triglyceride concentrations (P < 0.0001). The micromethods adapted and applied to the simultaneous detection of lipid peroxidation products and antioxidant status permit accurate and reliable assessment of the oxidative stress process in small plasma samples. Our results clearly show systemic peroxidative damage associated with insufficient defence mechanisms against ROS to be already present at clinical onset of type I diabetes mellitus in children and adolescents.
引用
收藏
页码:933 / 942
页数:10
相关论文
共 58 条
[1]
URIC-ACID PROVIDES AN ANTIOXIDANT DEFENSE IN HUMANS AGAINST OXIDANT-CAUSED AND RADICAL-CAUSED AGING AND CANCER - A HYPOTHESIS [J].
AMES, BN ;
CATHCART, R ;
SCHWIERS, E ;
HOCHSTEIN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (11) :6858-6862
[2]
ANTIOXIDANTS IN THE SERUM OF CHILDREN WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ASAYAMA, K ;
UCHIDA, N ;
NAKANE, T ;
HAYASHIBE, H ;
DOBASHI, K ;
AMEMIYA, S ;
KATO, K ;
NAKAZAWA, S .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (06) :597-602
[3]
Glycoxidation and lipoxidation in atherogenesis [J].
Baynes, JW ;
Thorpe, SR .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (12) :1708-1716
[4]
TOWARDS THE PHYSIOLOGICAL-FUNCTION OF URIC-ACID [J].
BECKER, BF .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (06) :615-631
[5]
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[6]
OXYGEN-RADICAL ABSORBENCY CAPACITY ASSAY FOR ANTIOXIDANTS [J].
CAO, GH ;
ALESSIO, HM ;
CUTLER, RG .
FREE RADICAL BIOLOGY AND MEDICINE, 1993, 14 (03) :303-311
[7]
VITAMIN-E REDUCTION OF PROTEIN GLYCOSYLATION IN DIABETES - NEW PROSPECT FOR PREVENTION OF DIABETIC COMPLICATIONS [J].
CERIELLO, A ;
GIUGLIANO, D ;
QUATRARO, A ;
DONZELLA, C ;
DIPALO, G ;
LEFEBVRE, PJ .
DIABETES CARE, 1991, 14 (01) :68-72
[8]
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy [J].
Ceriello, A ;
Morocutti, A ;
Mercuri, F ;
Quagliaro, L ;
Moro, M ;
Damante, G ;
Viberti, GC .
DIABETES, 2000, 49 (12) :2170-2177
[9]
Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid [J].
Chapple, ILC ;
Mason, GI ;
Garner, I ;
Matthews, JB ;
Thorpe, GH ;
Maxwell, SRJ ;
Whitehead, TP .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :412-421
[10]
CONTI M, 1991, CLIN CHEM, V37, P1273